If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP
National Kidney Foundation
@nkf
We’re fighting to eliminate preventable kidney disease, accelerate innovation, and dismantle structural inequities in kidney care. Join our fight.
884 Following 44K Followers 19K Posts
Latest posts 5
If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: bit.ly/4oN0ojP
This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: bit.ly/4oN0ojP
Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: bit.ly/3H23xMj
Join us virtually as we highlight real-world implementation data from NKF’s flagship CKDintercept program, a national strategy to improve CKD testing, diagnosis, and management in the primary care setting. RSVP: bit.ly/4niApQz
